Updates on fine chemical supply, documentation practice, sustainability disclosures, and process learning.
A personal take from a coatings industry veteran on why IFF's pharma divestiture aligns with the principle of prevention over cure, with a powder coating lesson that cost me $3,200.
Read moreA firsthand account of how choosing a budget small powder coating system for an electrical industry application almost derailed a pharma product launch — and why time certainty is worth the premium.
Read moreA practitioner's honest take on IFF's strategic divestiture of its pharma solutions business, with hard lessons on when to walk away and when to double down.
Read moreA practical FAQ for small pharma, coatings, and chemical buyers who are new to IFF. Written by someone who learned the hard way how to navigate IFF Store, pharma DMSO, biocides, and floor coatings.
Read moreAn honest look at what the IFF pharma solutions divestiture means for procurement professionals, why understanding product basics like powder coating appearance and biocide foggers matters, and how to avoid costly surprises.
Read moreA procurement manager breaks down when to use IFF's divestiture solutions, Arkema coatings resins, and water treatment chemicals – with real cost data and hidden fees you'll miss on a quote.
Read moreA quality compliance manager recounts a costly lesson in pharma material testing, revealing how digital integration—specifically LIMS—transformed their workflow, and what that means for IFF's pharma solutions and coatings clients.
Read moreA quality manager’s perspective on choosing specialty chemical suppliers for R&D trials, production scaling, and niche applications – with real cost implications and decision frameworks.
Read moreA purchasing administrator draws a parallel between choosing a powder coating line service provider and evaluating Key Opinion Leaders in the pharma industry—focusing on why trusting a vendor's 'expertise boundary' is more important than a promise of 'we can do everything.'
Read moreA quality inspector's take on IFF's pharma divestiture: transparency builds trust, and that applies to both corporate strategy and supplier pricing.
Read more